Dental Treatment with Osteoporosis and Bisphosphonates in Townsville

Osteoporosis is common across North Queensland, particularly among older women and men with long-term corticosteroid use. Many Townsville patients managing this condition are prescribed bisphosphonates – medications such as alendronate (Fosamax), risedronate, or the intravenous agent zoledronic acid – to reduce fracture risk by slowing bone resorption. A smaller but growing number are on denosumab (Prolia), a monoclonal antibody with similar skeletal effects. While these drugs provide real benefit for bone health, they also change how the jaw responds to dental procedures, and both patients and clinicians need to understand those implications before treatment begins.

The central concern is medication-related osteonecrosis of the jaw (MRONJ): a condition in which jaw bone loses its ability to heal after a surgical insult, leading to exposed, non-viable bone that resists standard treatment. Townsville’s dental community is alert to this risk because the city’s older demographic and high rates of osteoporosis prescribing mean the patient population is not small. Understanding your own risk category – and communicating it clearly to every dentist or specialist you see – is the most important step you can take to protect yourself.

Risk Stratification: Not All Bisphosphonate Patients Are the Same

The risk of MRONJ is not uniform across all patients taking these medications. The two most important variables are the route of administration and the duration of use.

Oral bisphosphonates taken for fewer than three years in a patient with no other significant risk factors carry a low, though not zero, risk of MRONJ. Most routine dental procedures, including carefully managed extractions, can still be performed in this group with appropriate precautions.

Risk rises meaningfully when oral bisphosphonate use extends beyond three years, particularly when combined with corticosteroid therapy, diabetes, smoking, or poor oral health. In these cases, the treating dentist should plan conservatively and consider specialist input for any surgical procedure.

Intravenous bisphosphonates represent a substantially higher risk category. Zoledronic acid, commonly used in oncology but also prescribed annually for osteoporosis, delivers a far greater drug load to bone than oral agents. Patients who have received IV bisphosphonates for cancer-related indications face MRONJ rates in published literature of up to 10 percent or higher following dento-alveolar surgery. Even patients receiving the lower annual osteoporosis dose should be considered elevated risk for invasive dental procedures.

Denosumab carries a comparable risk profile to bisphosphonates and the same precautions apply, though its effects on bone are reversible in theory – a nuance that does not meaningfully change clinical decision-making at the chair.

What to Tell Your Townsville Dentist

Before any dental appointment, bring or communicate the following information:

The exact name and dose of your bone medication
How long you have been taking it and the route (tablet, injection, infusion)
The condition being treated (osteoporosis versus cancer-related bone disease)
Any corticosteroids, chemotherapy, or immunosuppressants you are also taking
Your most recent bone density scan results if available
The name of the physician or specialist who manages your osteoporosis

This information allows your Townsville dentist to place you in the correct risk category before any treatment plan is finalised. It is far easier to adjust a treatment plan in advance than to manage an MRONJ complication after the fact. If you are unsure whether a medication you take is a bisphosphonate or antiresorptive agent, your pharmacist can confirm this quickly.

The Drug Holiday Debate

Many patients ask whether stopping their bisphosphonate before dental surgery will reduce MRONJ risk. For oral bisphosphonates, the current weight of evidence does not support a consistent benefit from a planned drug holiday. These drugs bind permanently to bone mineral and continue to exert biological effects for years after the last dose. A two- to three-month interruption does not meaningfully change the bone environment in the jaw.

The decision to pause medication should always involve the prescribing physician, who must weigh the fracture risk of interruption against the dental surgical risk. For most patients on alendronate for osteoporosis, the consensus is that the fracture risk from stopping outweighs any marginal dental benefit.

For patients on intravenous zoledronic acid, specialist consultation is essential and decisions are made case by case.

Conservative Dentistry: The Guiding Principle

When treating high-risk patients, Townsville dentists follow a principle of maximum conservation. This means:

Prioritising tooth retention over extraction wherever clinically feasible
Using endodontic treatment (root canal) to retain teeth that might otherwise be removed – see the root canal cost guide for Townsville for what this involves
Choosing dental crowns to restore broken teeth rather than extracting them – the dental crown cost guide covers options and pricing
Removing wisdom teeth electively before starting bisphosphonate therapy if indicated, rather than after
Ensuring excellent periodontal health to minimise the chance of future extractions being necessary

For patients who do require an extraction, atraumatic technique, primary wound closure, and careful post-operative monitoring are standard. Any sign of delayed healing warrants early review.

Regarding dental implants specifically, placement is considered a relative to absolute contraindication in high-risk patients. Even when osseointegration appears successful initially, late failure and MRONJ onset have both been documented. Patients interested in implants should read the dental implant cost guide for Townsville and understand that candidacy requires specialist clearance in this setting.

Specialist Referral in Townsville

If your general dentist identifies significant MRONJ risk or needs guidance on treatment planning, referral options in Townsville include oral and maxillofacial surgeons and oral medicine specialists. Townsville University Hospital accepts complex referrals and has the infrastructure to manage established MRONJ if that situation arises.

For patients requiring sedation during conservative procedures, the sedation dentistry cost guide explains what is available locally. Patients managing treatment costs alongside long-term medication expenses may also find the payment plan dentist guide and the bulk billing dentist guide useful for planning ahead.

Frequently asked questions

What is MRONJ and how does it affect dental treatment?

Medication-related osteonecrosis of the jaw (MRONJ) is a serious condition where jaw bone tissue dies and fails to heal, most commonly triggered by tooth extractions or implant surgery in patients taking bisphosphonates or denosumab. Once established, MRONJ is difficult to treat and can cause chronic pain, infection, and exposed bone. This is why Townsville dentists take a careful, conservative approach with any patient on these medications.

I take alendronate (Fosamax) for osteoporosis. Can I still have a tooth extracted?

Most patients on oral bisphosphonates like alendronate for fewer than three years and without other risk factors are considered low risk for MRONJ. Extraction is generally still possible, though your dentist will aim to minimise trauma, promote primary wound closure, and monitor healing closely. Longer duration of use, steroid co-medication, or diabetes raises the risk level. Always disclose your medication history before any procedure.

Should I take a drug holiday before dental surgery?

Current evidence does not consistently support stopping oral bisphosphonates before dental procedures. Because these drugs bind permanently to bone and remain active for years after cessation, a short drug holiday provides little measurable benefit for most oral bisphosphonate users. Your prescribing physician and dentist should make this decision together. For intravenous bisphosphonates, the situation is more complex and specialist input is essential.

Are dental implants safe for patients on bisphosphonates?

Dental implants are a relative to absolute contraindication for patients on intravenous bisphosphonates (such as zoledronic acid) and for those with a long history of oral bisphosphonate use combined with other risk factors. Even when implant placement appears successful initially, late implant failure and MRONJ onset can still occur. Any implant consideration for a patient on these medications in Townsville should involve specialist consultation before treatment planning.

Who should I see in Townsville if my dentist is concerned about MRONJ risk?

Your Townsville general dentist may refer you to an oral and maxillofacial surgeon or a specialist oral medicine practitioner for risk assessment and treatment planning. Townsville University Hospital and private specialist rooms in the CBD accept referrals for complex medication-related cases. Bring a full medication list, your most recent bone density scan results, and the name of your prescribing specialist to the consultation.

Dental Treatment with Osteoporosis and Bisphosphonates in Townsville